Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahn

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitorsK Deforche, R Camacho, Z Grossman, et al.
Nature Genetics|October 15, 1998
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding geneA J Coffey, R A Brooksbank, O Brandau, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitorsK Deforche, R Camacho, Z Grossman, et al.
Nature Genetics|October 15, 1998
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding geneA J Coffey, R A Brooksbank, O Brandau, et al.
Pageof 7